|

Dexrazoxane Hydrochloride Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Cardioxane, Totect, Zinecard

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Children's Oncology Group2
  • M.D. Anderson Cancer Center1

Indications

  • Cancer3
  • Acute Myeloid Leukemia2
  • Heart Disease1
  • Myeloid Sarcoma1
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells1

Birmingham, Alabama2 trials

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Children's Hospital of Alabama

Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Children's Hospital of Alabama

Phase 3

Houston, Texas1 trial

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.